60 day FRN

66906

Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Funded Asthma Program Recipients

Performance Measures Reporting
Tool.
Emergency Department Visits Reporting Form.
Hospital Discharge Reporting Form

30

1

150/60

75

30

1

30/60

15

30

1

30/60

15

...........................................................

........................

........................

........................

105

Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–26372 Filed 12–5–19; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Center
for Preparedness and Response, (BSC,
CPR); Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:

In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Center for Preparedness and Response,
(BSC, CPR). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates up to 60 people. Public
participants should pre-register for the
meeting (see SUPPLEMENTARY
INFORMATION for more information). The
public is also welcome to listen to the
meeting via Adobe Connect. Preregistration is required by clicking the
links below.
WEB ID January 23, 2020 registration:
https://adobeconnect.cdc.gov/
epvdyo95oxsu/event/registration.html.
WEB ID January 24, 2020 registration:
https://adobeconnect.cdc.gov/
ek6t1uq3f5zy/event/registration.html.
Dial in number: 1–888–790–2046;
Participant code: 5041683.
DATES: The meeting will be held on
January 23, 2020, 12:30 p.m. to 5:00
p.m., EST; and January 24, 2020, 8:30
a.m. to 2:30 p.m., EST.
ADDRESSES: Centers for Disease Control
and Prevention (CDC), Global
Communications Center, Building 19,
SUMMARY:

lotter on DSKBCFDHB2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

16:11 Dec 05, 2019

Jkt 250001

Auditorium B3, 1600 Clifton Road NE,
Atlanta, Georgia 30329–4027.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Office of Science and
Public Health Practice, CDC, 1600
Clifton Road NE, Mailstop H21–6,
Atlanta, Georgia 30329–4027;
Telephone: (404) 639–7450; Fax: (404)
471–8772; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Center for Preparedness and Response
(CPR), concerning strategies and goals
for the programs and research within
CPR, monitoring the overall strategic
direction and focus of the CPR Divisions
and Offices, and also may administer
and oversee peer review of CPR
scientific programs. For additional
information about the Board, please
visit: https://www.cdc.gov/cpr/bsc/
index.htm.
Matters to Be Considered: The twoday agenda will include: Day One: The
meeting will cover briefings and BSC
deliberation on the following topics: (1)
CPR Updates from the Director, (2) CPR
Interval Updates from the Division
Directors, and (3) the Report from the
Biological Agent Containment Working
Group (BACWG). Day Two: The meeting
will cover briefings and BSC
deliberation on the following topics: (1)
Current CDC Responses and the
Graduated Response Framework, (2)
Emergency Preparedness and Response
to Address Highest Burden and Need;
and (3) Preparedness Updates and CPR
Discussion: Liaison Representatives.
Agenda items are subject to change as
priorities dictate.
Members of the public that wish to
attend this meeting in person should
pre-register by submitting the following
information by email, facsimile, or
phone (see Contact Person for More

PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

Information) no later than 12:00 noon
(EDT) Friday, January 17, 2020:
• Full Name
• Organizational Affiliation
• Complete Mailing Address
• Citizenship
• Phone Number or Email Address
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–26329 Filed 12–5–19; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–1208; Docket No. CDC–2019–
0108]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed and/or
continuing information collection, as
required by the Paperwork Reduction

SUMMARY:

E:\FR\FM\06DEN1.SGM

06DEN1

lotter on DSKBCFDHB2PROD with NOTICES

Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices
Act of 1995. This notice invites
comment on Developmental Projects to
Improve the National Health and
Nutrition Examination Survey and
Related Programs. This generic
clearance request covers projects that
will help evaluate and improve upon
issues such as survey design and
operations, as well as examine the
feasibility and challenges that may arise
with developing future content for the
National Health and Nutrition
Examination Survey (NHANES) (OMB#
0920–0950, expires November 30, 2021)
or similar studies.
DATES: CDC must receive written
comments on or before February 4,
2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0108 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.

VerDate Sep<11>2014

16:11 Dec 05, 2019

Jkt 250001

The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Developmental Projects to Improve
the National Health and Nutrition
Examination Survey and Related
Programs, (OMB Control No. 0920–1208
Exp. Date 12/31/2020)—Revision—
National Center for Health Statistics
(NCHS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability; environmental,
social and other health hazards; and
determinants of health of the population
of the United States. The Division of
Health and Nutrition Examination
Surveys (DHNES) has conducted
national surveys and related projects
periodically between 1970 and 1994,
and continuously since 1999. The
mission of DHNES programs is to
produce descriptive statistics which
measure the health and nutrition status
of the general population. The
continuous operation of DHNES
programs presents unique challenges in
testing new survey content and
activities, such as outreach or
participant screening etc.
This generic request covers
developmental projects to help evaluate
and enhance DHNES existing and
proposed data collection activities to
increase research capacity and improve
data quality. The information collected
through this Generic Information

PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

66907

Collection Request will not be used to
make generalizable statements about the
population of interest or to inform
public policy. However, methodological
findings from these projects may be
reported.
The purpose and use of projects under
this NHANES generic clearance would
include developmental projects
necessary for activities such as; testing
new procedures, equipment, technology
and approaches that are going to be
folded into NHANES or other NCHS
programs; designing and testing
examination components or survey
questions; creating new studies
including biomonitoring and clinical
measures; creating new cohorts,
including a pregnancy and/or a birth—
24 month cohort; testing of the cognitive
and interpretive aspects of survey
methodology; feasibility testing of
proposed new components or
modifications to existing components;
testing of human-computer interfaces/
usability; assessing the acceptability of
proposed NHANES components among
likely participants; testing alternative
approaches to existing NHANES
procedures, including activities related
to improving nonresponse; testing the
use of or variations/adjustments in
incentives; testing content of web based
surveys; testing the feasibility of
obtaining bodily fluid specimens (blood,
urine, semen, saliva, breastmilk) and
tissue sample (swabs); testing digital
imaging technology and related
procedures (e.g., retinal scan, liver
ultrasound, Dual-energy X-ray
absorptiometry (DEXA), prescription
and over-the-counter dietary
supplements bottles); testing the
feasibility of and procedure/processes
for accessing participant’s medical
records from healthcare settings (e.g.,
hospitals and physician offices); testing
the feasibility and protocols for home
examination measurements; testing
survey materials and procedures to
improve response rates, including
changes to advance materials and
protocols, changes to the incentive
structure, introduction of new and
timely outreach and awareness
procedures including the use of social
media; conducting crossover studies;
creating and testing digital survey
materials; and conducting customer
satisfaction assessments.
The types of participants covered by
the NHANES generic may include
current or past NHANES participants;
family or household members of
NHANES participants; individuals
eligible to be participants in NHANES,
but who did not screen into the actual
survey; convenience samples;
volunteers; subject matter experts or

E:\FR\FM\06DEN1.SGM

06DEN1

66908

Federal Register / Vol. 84, No. 235 / Friday, December 6, 2019 / Notices

consultants such as survey
methodologist, academic researchers,
clinicians or other health care providers;
NHANES data or website users;
members of the general public or
individuals abroad who would be part
of a collaborative development project

or projects between NCHS and related
public health agencies in the U.S. and/
or abroad. The type of participant
involved in a given developmental
project would be determined by the
nature of the project. The details of each

project will be included in the specific
GenIC submissions.
There is no cost to respondents other
than their time. A three-year clearance
is requested. The estimated annualized
burden hours for this generic data
collection is 59,465.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Form name

Individuals or Households .................

Developmental Projects & Focus
Group documents.
Developmental Projects & Focus
Group documents.
24-hour developmental projects .......

35,000

1

1.5

52,500

300

1

1.5

450

200

1

25

5,000

Developmental Projects ...................
Focus Group/Developmental Project
Documents.

1,000
15

1
1

1.5
1

1,500
15

...........................................................

........................

........................

........................

59,465

Volunteers .........................................
Individuals or households, Volunteers, NHANES Participants.
NHANES participants ........................
Subject Matter Experts .....................
Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–26374 Filed 12–5–19; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1011]

Agency Forms Undergoing Paperwork
Reduction Act Review

lotter on DSKBCFDHB2PROD with NOTICES

Number of
respondents

Type of respondents

In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Emergency
Epidemic Investigation Data Collections
(OMB control number 0920–1011), for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 4, 2019 to obtain comments
from the public and affected agencies.
CDC did not receive comments related
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the

VerDate Sep<11>2014

16:11 Dec 05, 2019

Jkt 250001

functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Emergency Epidemic Investigation
Data Collections (OMB Control No.
0920–1011, Exp. 01/31/2020)—
Extension—Center for Surveillance,
Education, and Laboratory Services

PO 00000

Frm 00039

Fmt 4703

Sfmt 4703

(CSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC previously conducted Emergency
Epidemic Investigations (EEIs) under
Office of Management and Budget
(OMB) Control Number 0920–0008. In
2013, CDC received OMB approval
(OMB Control Number 0920–1011) for a
new OMB generic clearance for a threeyear period to collect vital information
during EEIs in response to urgent
outbreaks or events (i.e., natural,
biological, chemical, nuclear,
radiological) characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors. This generic
clearance was approved for a three-year
extension, which expires on 1/31/2020.
CDC seeks OMB approval for an
extension of this generic clearance for
an additional three-year period.
Supporting effective emergency
epidemic investigations is one of the
most important ways that CDC protects
the health of the public. CDC is
frequently called upon to conduct EEIs
at the request of local, state, or
international health authorities seeking
support to respond to urgent outbreaks
or urgent public health-related events.
In response to external partner requests,
CDC provides necessary epidemiologic
support to identify the agents, sources,
modes of transmission, or risk factors to
effectively implement rapid prevention
and control measures to protect the
public’s health. Data collection is a
critical component of the epidemiologic
support provided by CDC; data are

E:\FR\FM\06DEN1.SGM

06DEN1